Intrinsic Value of S&P & Nasdaq Contact Us

Athira Pharma, Inc. ATHA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+166.7%

Stock Statistics — ATHA

Athira Pharma, Inc. (ATHA) has a market capitalization of $26.62M and trades at $6.75. The 52-week range is 2.1955-8.36.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-24.70.

The stock has a beta of 2.80, operates in the Healthcare sector.

Trading Data
Current Price$6.75
52-Week Range2.1955-8.36
Volume70.31K
Avg Volume (30D)1.06M
Market Cap$26.62M
Beta (1Y)2.80
Company
IPO Date2020-09-18
Employees26
CEOMark J. Litton
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS04746L2034
CUSIP04746L203
Income (Latest Year)
Gross Profit$-68.09M
EBITDA$-102.27M
Operating Income$-102.27M
Net Income$-105.61M
EPS$-24.70
EPS Diluted$-24.70
Shares Outstanding$4.28M
Balance Sheet (Latest Year)
Total Assets$92.15M
Current Assets$89.46M
Cash & ST Investments$88.33M
Total Liabilities$64.36M
Total Debt$803K
Net Debt$-68.47M
Total Equity$27.79M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-0.3
P/B Ratio0.96
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message